Related references
Note: Only part of the references are listed.Variation Among Patients With Crohn's Disease in Benefit vs Risk Preferences and Remission Time Equivalents
Meenakshi Bewtra et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations
F. Reed Johnson et al.
VALUE IN HEALTH (2019)
QALYs without bias? Nonparametric correction of time trade-off and standard gamble weights based on prospect theory
Stefan A. Lipman et al.
HEALTH ECONOMICS (2019)
Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease
Frank I. Scott et al.
INFLAMMATORY BOWEL DISEASES (2019)
Discrete Choice Experiments in Health Economics: Past, Present and Future
Vikas Soekhai et al.
PHARMACOECONOMICS (2019)
Discounting in Economic Evaluations
Arthur E. Attema et al.
PHARMACOECONOMICS (2018)
Quality-Adjusted Life-Years without Constant Proportionality
Benjamin M. Craig et al.
VALUE IN HEALTH (2018)
A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]
Louis P. Garrison et al.
VALUE IN HEALTH (2018)
Discounting health and money: New evidence using a more robust method
Arthur E. Attema et al.
JOURNAL OF RISK AND UNCERTAINTY (2018)
Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment
Marcel F. Jonker et al.
HEALTH ECONOMICS (2017)
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
Lowell E. Schnipper et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force
A. Brett Hauber et al.
VALUE IN HEALTH (2016)
Measuring Discounting without Measuring Utility
Arthur E. Attema et al.
AMERICAN ECONOMIC REVIEW (2016)
Cost-Effectiveness Analysis Alongside Clinical Trials II-An ISPOR Good Research Practices Task Force Report
Scott D. Ramsey et al.
VALUE IN HEALTH (2015)
Validation of the Underlying Assumptions of the Quality-Adjusted Life-Years Outcome: Results from the ECHOUTCOME European Project
Ariel Beresniak et al.
PHARMACOECONOMICS (2015)
Discrete Choice Experiments in Health Economics: A Review of the Literature
Michael D. Clark et al.
PHARMACOECONOMICS (2014)
Evaluating Migraineurs' Preferences for Migraine Treatment Outcomes Using a Choice Experiment
Juan M. Gonzalez et al.
HEADACHE (2013)
Discrete choice experiments in health economics: a review of the literature
Esther W. de Bekker-Grob et al.
HEALTH ECONOMICS (2012)
Valuing the environmental, cultural and social impacts of open-cut coal mining in the Hunter Valley of New South Wales, Australia
Robert Gillespie et al.
JOURNAL OF ENVIRONMENTAL ECONOMICS AND POLICY (2012)
Weight-Related Quality of Life, Health Utility, Psychological Well-Being, and Satisfaction With Exenatide Once Weekly Compared With Sitagliptin or Pioglitazone After 26 Weeks of Treatment
Jennie H. Best et al.
DIABETES CARE (2011)
The correction of TTO-scores for utility curvature using a risk-free utility elicitation method
Arthur E. Attema et al.
JOURNAL OF HEALTH ECONOMICS (2009)
Hyperbolic discounting and the standard model: Eliciting discount functions
Jawwad Noor
JOURNAL OF ECONOMIC THEORY (2009)
INCORPORATING FEELINGS RELATED TO THE UNCERTAINTY ABOUT FUTURE HEALTH IN UTILITY MEASUREMENT
Afschin Gandjour
HEALTH ECONOMICS (2008)
Current health and preferences for life-prolonging treatments: An application of prospect theory to end-of-life decision making
Laraine Winter et al.
SOCIAL SCIENCE & MEDICINE (2007)
Conjoint-analysis QALYs for acute conditions
F. R. Johnson et al.
VALUE IN HEALTH (2006)
Towards a better QALY model
Jose-Maria Abellan-Perpinan et al.
HEALTH ECONOMICS (2006)
Pharmacoeconomics: Historical perspective
JL Bootman et al.
ANNALS OF PHARMACOTHERAPY (2006)
Utility measurement in healthcare - The things I never got to
George W. Torrance
PHARMACOECONOMICS (2006)
A semi-separable utility function for health profiles
AM Guerrero et al.
JOURNAL OF HEALTH ECONOMICS (2005)
A characterization of quality adjusted life-years under cumulative prospect theory
H Bleichrodt et al.
MATHEMATICS OF OPERATIONS RESEARCH (2003)
A new explanation for the difference between time trade-off utilities and standard gamble utilities
H Bleichrodt
HEALTH ECONOMICS (2002)
Share Paper
